30 % Faster implementation. Quick results. No consultants.

Accelerate GMP pharma projects without compliance risk

We identify and resolve bottlenecks in technology transfer, scale-up, validation, and QA.

GMP-compliant implementation strategies that shorten critical project paths for tech transfer, scale-up, and QA projects by 30-40% while ensuring full regulatory control

Monitoring and control of CDMOs; stabilizing supply chains;

We all have many years of operational experience and implement projects completely.

Project partner

SMEs and corporations
from Switzerland and Europe

Regions and Countries

Projects in Switzerland – EU – China – Japan – USA

“Hands-on management experience

MSAT & Manufacturing & Quality Supply Chain & Regulatory

Case studies with our customers

4 months faster

Program Management:

Construction of production buildings

High time pressure, complex logistics
15 months instead of 19 months
(Brownfield / Greenfield Project) Customer: DAX Corporation

Production transfer

Overall Project Management:

Emergency production transfer

Extreme time pressure

6 months instead of 18 months
Customer: Mid-sized pharmaceutical company

500 million € in Time &
Within budget

Program Management:

Complex coordination of new factory construction, time pressure

Customer: DAX corporation

4 months faster

production building
(Brownfield / Greenfield project) DAX corporation

Production transfer

Emergency production transfer
Pharmaceutical SMEs ; Germany

€500 million

Our largest project, new factory construction for the Dax group

What delays really cost

Late revenue

Unmet quarterly figures generate unnecessary discussions

Bound capacity

Additional capacity for the delayed project slows down other activities

Compensation costs

Additional staff, unnecessary repetitions cause unplanned additional costs

4 months faster

production building
(Brownfield / Greenfield project) DAX corporation

Production transfer

Emergency production transfer
Pharmaceutical SMEs ; Germany

€500 million

Our largest project, new factory construction for the Dax group

Where pharma projects lose time

No IT or software question

Almost never do projects get delayed because of the wrong software or insufficient IT infrastructure. It is often these problems:

If these problems are not resolved, project times and costs will double

pharma project timeline infographic

Typical delays in GMP projects

Transfer delayed

Systems are not 1:1 comparable
Minor adjustments are necessary

Delayed validation

Additional coordination between QA, production, and the customer is necessary.

Delay in delivery

The already long lead times for components are being exceeded

4 months faster

production building
(Brownfield / Greenfield project) DAX corporation

Production transfer

Emergency production transfer
Pharmaceutical SMEs ; Germany

€500 million

Our largest project, new factory construction for the Dax group

6 levers to accelerate projects

In our experience, technical and technological obstacles are very rarely the real trouble spots of projects and processes.

Implementation in practice

There are numerous theories on project management, and they are easy to look up. Implementation is something you learn over the years. Only solid implementation brings real cost advantages.

External support

With a few months of external support, you reorganize the projects and achieve a very fast and therefore cost-effective implementation.

Risk reduction

External experts build on their experience. This allows processes to be targetedly improved while simultaneously reducing the GMP risk.

Technical optimization

We perform optimizations using simulations based on measurement data and laboratory tests. This reduces costs to 10 % compared to production trials.

Simple SOPs

When SOPs no longer work, we overhaul, streamline, and simplify them. This is how a simple document change improves the economic result.

Technology & GMP

Technique and technology are coordinated with each other right from the start. This simplifies complex technology transfers and ensures they are carried out safely.

Check where your project is losing time

Identify project bottlenecks

We measure our project success

We measure the performance

In the technical field, it is easier to measure process performance. However, it is more important in administrative processes such as quality, regulatory, and business development. Measurement is necessary in order to improve.

gauge without numbers but with pointer

What's in it for you as a decision-maker?

The total duration of a project (e.g., technology transfers) determines the total costs of the projects and business processes.

The project duration directly determines costs, revenue, and capacity utilization.

Here are some of the important benefits

improved pharma project timeline infographic

Discuss time and cost potential

Confidential and non-binding

When our approach does not work

For the implementation of our project, there are prerequisites that must fit.

Escalated customer-supplier situation

Our methods are not suitable for resolving conflicts between customers and suppliers.

We can facilitate conflict resolution, but we do not conduct it ourselves.

Unstable environment

Various restructurings are already running in parallel. Then we cannot carry out a realistic measurement of success.

We always measure success during our implementations. On the one hand, against the established project schedule and budget, but we also pursue internal goals: determining our own processing times and implementation times, for example. If too many parallel projects are running, we can no longer measure and control the success of our project.

Let's have an exchange of thoughts on that.

Have a GMP pharma project reviewed

Have the duration and potential of your project evaluated

How much will my project really cost?

If you are asking this question, you have probably already experienced unpleasant surprises.

Our project costs are billed on a time and materials basis. During the very first conversation, we provide an initial estimate of time and costs. This budget framework holds true. The total costs are lower the faster we are allowed to be.

Cost transparency and cost control according to
Project times and sections

project dashboard

Eoswiss Pharma compared to large consulting firms

Why do we make our projects better? We are experienced specialists in our core areas. Large consulting firms have neither this knowledge nor this experience. 
We conduct active research ourselves - so we are always up to date.

Content 2
Content 1 1

Custom tools for our projects

We use these processes and tools the most

We link production data and laboratory data to create meaningful tools. Improvement of raw materials, APIs, and finished products.

Development of freeze-drying cycles. Scale-up & scale-down. Technology transfer of freeze-drying processes.

Scale-up and process development. Modeling of processes using mathematical and statistical models.

Optimization and Process Development
including Design of Experiments (DoE), optimization of plants during ongoing production, and process simulations

Process Analytical Technology (PAT)

Linking experimental data to models. Use of these models for process development and optimization.

Finding robust production parameters. This is where manufacturing profitability lies.

Quality management under GMP (pharma, medical technology, chemistry, industry) or ISO 9001, ISO 13485

We are working on optimizing warehouses, transit routes, and buffers for future expansions and modifications.

Our project management also includes change management. This is the only way to achieve sustainable implementation.

Without implementation, no project helps.

Technology transfer

Transfer of technologies, production facilities, expansion and conversion of plants

Analytic Transfer

Transfer of analytical methods under GMP including validations, verifications with all necessary documents

Professional process optimizations (in cooperation with Japanese specialists).

Custom tools for our projects

We use these processes and tools the most

Scale-up and process development.

Custom software development for tailored solutions

Development of freeze-drying cycles. Scale-up & scale-down. Technology transfer of freeze-drying processes.

Scale-up and process development. Modeling of processes using mathematical and statistical models.

Optimization and Process Development
including Design of Experiments (DoE), optimization of plants during ongoing production, and process simulations

Process Analytical Technology (PAT)

Linking experimental data to models. Use of these models for process development and optimization.

Finding robust production parameters. This is where manufacturing profitability lies.

Quality management under GMP (pharma, medical technology, chemistry, industry) or ISO 9001, ISO 13485

We are working on optimizing warehouses, transit routes, and buffers for future expansions and modifications.

Our project management also includes change management. This is the only way to achieve sustainable implementation.

Without implementation, no project helps.

Transfer of technologies, production facilities, expansion and conversion of plants

Transfer of analytical methods under GMP including validations, verifications with all necessary documents

Professional process optimizations (in cooperation with Japanese specialists).

Frequently Asked Questions (FAQ)

How can pharmaceutical projects be implemented faster?

Pharma projects can be implemented faster if implementation bottlenecks are identified early and specifically resolved. Crucial factors are clear responsibilities, close coordination between MSAT, QA, and production, as well as active management of CDMOs. As a result, delays in technology transfer and validation can be significantly reduced.

Why are GMP projects delayed so often?

GMP projects are frequently delayed by the overload of MSAT and QA teams, a lack of alignment between departments, and insufficient control over external partners such as CDMOs. These factors lead to delays in technology transfer, validation, and batch release while simultaneously increasing compliance risk.

How do you reduce GMP risks in projects?

GMP risks can be reduced if quality requirements are integrated into implementation from the outset. This includes close coordination between QA, MSAT, and manufacturing, as well as consistent documentation along the actual process. Early identification of deviations prevents issues during audits and inspections.

How do you improve collaboration with CDMOs?

Collaboration with CDMOs is improved through clear governance structures, transparent communication, and active management of external partners. It is important that progress, risks, and responsibilities are continuously monitored to avoid delays and quality issues.

When should external experts be used in pharma projects?

External experts are useful when projects are delayed, validations fail, or internal teams are overburdened. They help to quickly identify bottlenecks, accelerate decisions, and bring projects back under control.

How can technology transfer in pharma be accelerated?

Technology transfer can be accelerated by clear process definitions, early alignment between MSAT, QA, and production, as well as structured management of CDMOs. The key is to identify risks early and manage them actively rather than acting reactively.

Have GMP project reviewed

Have the duration and potential of your project evaluated